| pubmed-article:9002765 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9002765 | lifeskim:mentions | umls-concept:C0021670 | lld:lifeskim |
| pubmed-article:9002765 | lifeskim:mentions | umls-concept:C0475264 | lld:lifeskim |
| pubmed-article:9002765 | lifeskim:mentions | umls-concept:C0040399 | lld:lifeskim |
| pubmed-article:9002765 | lifeskim:mentions | umls-concept:C0298998 | lld:lifeskim |
| pubmed-article:9002765 | pubmed:issue | 4 Suppl 1 | lld:pubmed |
| pubmed-article:9002765 | pubmed:dateCreated | 1997-3-6 | lld:pubmed |
| pubmed-article:9002765 | pubmed:abstractText | We evaluated the sensitivity of 111In-Octreotide scintigraphy in the diagnosis of pancreatic insulinoma in a selected number of patients. In addition, we compared the results of scintigraphy with those of other conventional diagnostic techniques. Seven patients with surgically confirmed insulinoma (< 1.5 cm in diameter) of the pancreas were studied. Before surgery, patients underwent arteriography with Ca-gluconate, CT scan, and 111In-Octreotide scintigraphy. 111In-Octreotide scintigraphy showed a higher diagnostic specificity (85%) than selective arteriography (83%) or CT scan (57%). We conclude that 111In-Octreotide scintigraphy should always be performed before surgery in cases of pancreatic insulinoma and that a SPECT acquisition should be performed both 6 and 24 hours post-injection in order to increase the diagnostic sensitivity of the test. | lld:pubmed |
| pubmed-article:9002765 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9002765 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9002765 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9002765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9002765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9002765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9002765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9002765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9002765 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9002765 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9002765 | pubmed:issn | 1125-0135 | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:TamburranoGG | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:SalernoGG | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:ProcacciniEE | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:SignoreAA | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:RongaGG | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:ChianelliMM | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:LeonettiFF | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:IozzoPP | lld:pubmed |
| pubmed-article:9002765 | pubmed:author | pubmed-author:AnnovazziAA | lld:pubmed |
| pubmed-article:9002765 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9002765 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:9002765 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9002765 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9002765 | pubmed:pagination | 111-2 | lld:pubmed |
| pubmed-article:9002765 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:meshHeading | pubmed-meshheading:9002765-... | lld:pubmed |
| pubmed-article:9002765 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:9002765 | pubmed:articleTitle | SPECT imaging with 111In-octreotide for the localization of pancreatic insulinoma. | lld:pubmed |
| pubmed-article:9002765 | pubmed:affiliation | Special Service of Nuclear Medicine, II Medical Clinic, University La Sapienza, Rome, Italy. | lld:pubmed |
| pubmed-article:9002765 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9002765 | pubmed:publicationType | Comparative Study | lld:pubmed |
